Synergistic Effect of Geranylgeranyltransferase Inhibitor, GGTI, and Docetaxel on the Growth of Prostate Cancer Cells.

about

Preparation and characterization of surface-modified PLGA-polymeric nanoparticles used to target treatment of intestinal cancer.Ral signaling pathway in health and cancer.

P2860

Q36371642-462BDF5E-0F98-41C4-8204-2E53B33729DE Q47124416-CBC4C19F-8942-495F-A8E5-89C93FB30C13

P2860

Synergistic Effect of Geranylgeranyltransferase Inhibitor, GGTI, and Docetaxel on the Growth of Prostate Cancer Cells.

Item

http://www.wikidata.org/entity/Q38730156

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Synergistic Effect of Geranylg ...... owth of Prostate Cancer Cells.

@en

type

Item

label

Synergistic Effect of Geranylg ...... owth of Prostate Cancer Cells.

@en

prefLabel

Synergistic Effect of Geranylg ...... owth of Prostate Cancer Cells.

@en

P1476

Synergistic Effect of Geranylg ...... owth of Prostate Cancer Cells.

@en

P2093

Bin Han

http://www.w3.org/2001/XMLSchema#string

Mizuki Kobayashi

http://www.w3.org/2001/XMLSchema#string

Naohiro Fujimoto

http://www.w3.org/2001/XMLSchema#string

Tetsuro Matsumoto

http://www.w3.org/2001/XMLSchema#string

P2860

The bisphosphonate, zoledronic acid, induces apoptosis of breast cancer cells: evidence for synergy with paclitaxel

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer

Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer

Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial

Zoledronic acid treatment impairs protein geranyl-geranylation for biological effects in prostatic cells.

Emerging anti-cancer molecular mechanisms of aminobisphosphonates.

A third-generation bisphosphonate, minodronic acid (YM529), successfully prevented the growth of bladder cancer in vitro and in vivo.

Molecular mechanisms of action of bisphosphonates: current status.

Zoledronic acid induces apoptosis and inhibits adhesion to mineralized matrix in prostate cancer cells via inhibition of protein prenylation.

P304

989214

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2012/989214

http://www.w3.org/2001/XMLSchema#string

P478

2012

http://www.w3.org/2001/XMLSchema#string

P577

2011-06-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51824546

http://www.w3.org/2001/XMLSchema#string

P698

22111007

http://www.w3.org/2001/XMLSchema#string

P921

cabazitaxel

P932

3195320

http://www.w3.org/2001/XMLSchema#string

Synergistic Effect of Geranylgeranyltransferase Inhibitor, GGTI, and Docetaxel on the Growth of Prostate Cancer Cells.

about

P2860

P2860

Synergistic Effect of Geranylgeranyltransferase Inhibitor, GGTI, and Docetaxel on the Growth of Prostate Cancer Cells.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P5875

P698

P921

P932